These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16464437)

  • 21. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methicillin-resistant commensal staphylococci in healthy dogs as a potential zoonotic reservoir for community-acquired antibiotic resistance.
    Epstein CR; Yam WC; Peiris JS; Epstein RJ
    Infect Genet Evol; 2009 Mar; 9(2):283-5. PubMed ID: 19073283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene.
    Wang JL; Wang JT; Chen SY; Hsueh PR; Kung HC; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):365-71. PubMed ID: 17878063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to reduce antibiotic resistance in the community.
    Cohen R
    Pediatr Infect Dis J; 2006 Oct; 25(10):977-80. PubMed ID: 17006310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
    Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increase of bacterial resistance in human medicine by resistance genes of bacteria from meat supplying animals].
    Wagner J; Hahn H
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):380-4. PubMed ID: 10598355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic-resistant bacterial sepsis in Papua New Guinea.
    Duke T
    P N G Med J; 2000; 43(1-2):82-90. PubMed ID: 11407623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit.
    Huskins WC
    Curr Opin Crit Care; 2007 Oct; 13(5):572-7. PubMed ID: 17762238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.
    Miller LG; Perdreau-Remington F; Bayer AS; Diep B; Tan N; Bharadwa K; Tsui J; Perlroth J; Shay A; Tagudar G; Ibebuogu U; Spellberg B
    Clin Infect Dis; 2007 Feb; 44(4):471-82. PubMed ID: 17243048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J; Lieberman JM
    Pharmacotherapy; 2006 Dec; 26(12):1758-70. PubMed ID: 17125437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global resistance trends and the potential impact on empirical therapy.
    Isturiz R
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):113-9. PubMed ID: 16934705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.